Research Article
Application Value of Combined Detection of NLR, PNI, D-Dimer, CD3+ T Lymphocytes, and CEA in Colorectal Cancer Screening
Table 4
The relationship between NLR, PNI, D-D, CD3+ T, and CEA levels with clinicopathological characteristics of CRC patients.
| Characteristics | CEA (ng/ml) | NLR | PNI | D-D (ng/ml) | CD3+ T (μL-1) | ≤2.73 | >2.73 | | ≤1.95 | >1.95 | | ≤51.3 | >51.3 | | ≤89 | >89 | | ≤760 | >760 | |
| Sex | | | | | | | | | | | | | | | | Male | 30 | 86 | 0.173 | 41 | 75 | 0.131 | 86 | 30 | 0.336 | 29 | 87 | 0.702 | 66 | 50 | 0.311 | Female | 25 | 46 | | 33 | 38 | | 48 | 23 | | 16 | 55 | | 35 | 36 | | Age (yr) | | | | | | | | | | | | | | | | <63 | 37 | 55 | 0.001 | 42 | 50 | 0.094 | 63 | 29 | 0.342 | 33 | 59 | <0.001 | 57 | 35 | 0.032 | ≥ 63 | 18 | 77 | | 32 | 63 | | 71 | 24 | | 12 | 83 | | 44 | 51 | | Tumor location | | | | | | | | | | | | | | | | Colon | 33 | 64 | 0.151 | 37 | 60 | 0.678 | 66 | 31 | 0.255 | 25 | 72 | 0.570 | 84 | 13 | <0.001 | Rectum | 22 | 68 | | 37 | 53 | | 68 | 22 | | 20 | 70 | | 17 | 73 | | Histological type | | | | | | | | | | | | | | | | Nonspecific adenocarcinoma | 54 | 128 | 1.000 | 73 | 109 | 0.650 | 129 | 53 | 0.324 | 44 | 138 | 1.000 | 99 | 88 | 0.663 | Others | 1 | 4 | | 1 | 4 | | 5 | 0 | | 1 | 4 | | 2 | 3 | | Differentiation degree | | | | | | | | | | | | | | | | Well+moderate | 46 | 92 | 0.048 | 59 | 79 | 0.135 | 97 | 41 | 0.486 | 39 | 99 | 0.024 | 74 | 64 | 0.858 | Poor | 9 | 40 | | 15 | 34 | | 37 | 12 | | 6 | 43 | | 27 | 22 | | Vascular invasion | | | | | | | | | | | | | | | | Yes | 9 | 35 | 0.136 | 18 | 26 | 0.836 | 31 | 13 | 0.84 | 8 | 36 | 0.297 | 27 | 17 | 0.263 | No | 46 | 97 | | 56 | 87 | | 103 | 40 | | 37 | 106 | | 74 | 69 | | Nerve invasion | | | | | | | | | | | | | | | | Yes | 12 | 54 | 0.013 | 29 | 37 | 0.367 | 49 | 17 | 0.562 | 16 | 50 | 0.966 | 31 | 35 | 0.154 | No | 43 | 78 | | 45 | 76 | | 85 | 36 | | 29 | 92 | | 70 | 51 | | Tumor size (cm) | | | | | | | | | | | | | | | | < 5 | 44 | 88 | 0.068 | 59 | 73 | 0.026 | 89 | 43 | 0.047 | 38 | 94 | 0.019 | 70 | 62 | 0.677 | ≥ 5 | 11 | 44 | | 15 | 40 | | 45 | 10 | | 7 | 48 | | 31 | 24 | | TNM stage | | | | | | | | | | | | | | | | 0, I, II | 40 | 60 | 0.001 | 35 | 65 | 0.170 | 72 | 28 | 0.911 | 25 | 75 | 0.748 | 55 | 45 | 0.771 | III, IV | 15 | 72 | | 39 | 48 | | 62 | 25 | | 20 | 67 | | 46 | 41 | | T stage | | | | | | | | | | | | | | | | | 21 | 22 | 0.001 | 18 | 25 | 0.727 | 31 | 12 | 0.942 | 15 | 28 | 0.059 | 19 | 24 | 0.141 | | 34 | 110 | | 56 | 88 | | 103 | 41 | | 30 | 114 | | 82 | 62 | | Lymph node metastasis | | | | | | | | | | | | | | | | N0 | 40 | 61 | 0.001 | 36 | 65 | 0.234 | 73 | 28 | 0.839 | 25 | 76 | 0.811 | 56 | 45 | 0.670 | | 15 | 71 | | 38 | 48 | | 61 | 25 | | 20 | 66 | | 45 | 41 | | Distant metastasis | | | | | | | | | | | | | | | | Yes | 2 | 20 | 0.026 | 10 | 12 | 0.548 | 17 | 5 | 0.534 | 3 | 19 | 0.223 | 12 | 10 | 0.957 | No | 53 | 112 | | 64 | 101 | | 117 | 48 | | 42 | 123 | | 89 | 76 | |
|
|